EKF Diagnostics Holdings plc (AIM: EKF)
London
· Delayed Price · Currency is GBP · Price in GBX
27.00
+1.30 (5.06%)
Jan 17, 2025, 4:35 PM GMT+1
EKF Diagnostics Holdings Revenue
EKF Diagnostics Holdings had revenue of 25.21M GBP in the half year ending June 30, 2024, a decrease of -32.72%. This brings the company's revenue in the last twelve months to 50.95M, down -9.07% year-over-year. In the year 2023, EKF Diagnostics Holdings had annual revenue of 52.61M, down -21.05%.
Revenue (ttm)
50.95M
Revenue Growth
-9.07%
P/S Ratio
2.29
Revenue / Employee
164.89K
Employees
317
Market Cap
116.61M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 52.61M | -14.02M | -21.05% |
Dec 31, 2022 | 66.64M | -15.20M | -18.57% |
Dec 31, 2021 | 81.84M | 16.58M | 25.40% |
Dec 31, 2020 | 65.26M | 20.34M | 45.29% |
Dec 31, 2019 | 44.92M | 2.37M | 5.58% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |